Compile Data Set for Download or QSAR
maximum 50k data
Found 62 Enz. Inhib. hit(s) with all data for entry = 9639
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477630(5-(3-(3-(6-Fluorobenzo[b]thiophen-3-yl)azetidin-1-...)
Affinity DataIC50:  1.20E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477658(1-(1-(5-(Ethoxymethyl)-4-(6-methoxypyridin-3-yl)-4...)
Affinity DataIC50:  1.40E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477653(4-(1-(5-((Difluoromethoxy)methyl)-4-(6-methoxypyri...)
Affinity DataIC50:  1.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477638(5-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  2.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477654(6-Fluoro-1-(1-(4-(6-methoxypyridin-3-yl)-5-(triflu...)
Affinity DataIC50:  2.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477651(Methyl ((5-(3-(6-fluoro-3,4-dihydroquinolin-1(2H)-...)
Affinity DataIC50:  2.10E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477633(5-(3-(3-(6-Fluorobenzofuran-3-yl)azetidin-1-yl)-5-...)
Affinity DataIC50:  2.30E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(3-Chloro-1-(1-(5-(ethoxymethyl)-4-(6-methoxypyridi...)
Affinity DataIC50:  2.30E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477644(1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(methoxymet...)
Affinity DataIC50:  2.40E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477640(5-(3-(3-(7-Fluorobenzodihydropyran-4-yl)azetidin-1...)
Affinity DataIC50:  2.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477639(5-Fluoro-1-(1-(4-(6-methoxypyridin-3-yl)-5-methyl-...)
Affinity DataIC50:  3.10E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477648(4-(1-(5-(Ethoxymethyl)-4-(6-methoxypyridin-3-yl)-4...)
Affinity DataIC50:  3.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477636(5-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  4.40E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477656(6-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  4.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477624(5-(3-(3-(6-Fluoronaphthalen-1-yl)azetidin-1-yl)-5-...)
Affinity DataIC50:  4.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477627(5-Fluoro-1-(1-(4-(6-methoxypyridin-3-yl)-5-methyl-...)
Affinity DataIC50:  4.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477624(5-(3-(3-(6-Fluoronaphthalen-1-yl)azetidin-1-yl)-5-...)
Affinity DataIC50:  4.90E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(3-Chloro-1-(1-(5-(ethoxymethyl)-4-(6-methoxypyridi...)
Affinity DataIC50:  5.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477648(4-(1-(5-(Ethoxymethyl)-4-(6-methoxypyridin-3-yl)-4...)
Affinity DataIC50:  5.80E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477645(6-Fluoro-1-(1-(4-(6-methoxypyridin-3-yl)-5-methyl-...)
Affinity DataIC50:  6.20E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477647(6-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  6.70E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477629(5-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  6.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477625(1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(methoxymet...)
Affinity DataIC50:  7.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477641(8-Fluoro-4-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  7.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477657(7-Fluoro-4-(1-(4-(6-methoxypyridin-3-yl)-5-(triflu...)
Affinity DataIC50:  7.90E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477647(6-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  8.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477655((5-(3-(6-Fluoronaphthalen-1-yl)azetidin-1-yl)-4-(6...)
Affinity DataIC50:  9.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477659(1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(ethoxymeth...)
Affinity DataIC50:  9.10E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477642(7-Fluoro-4-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.07E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477636(5-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.09E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477635(6-Fluoro-3-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.09E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477635(6-Fluoro-3-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.18E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477634(5-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.19E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477645(6-Fluoro-1-(1-(4-(6-methoxypyridin-3-yl)-5-methyl-...)
Affinity DataIC50:  1.21E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(3-Chloro-1-(1-(5-(ethoxymethyl)-4-(6-methoxypyridi...)
Affinity DataIC50:  1.24E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477630(5-(3-(3-(6-Fluorobenzo[b]thiophen-3-yl)azetidin-1-...)
Affinity DataIC50:  1.25E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477659(1-(1-(4-(Benzo[d][1,3]dioxolan-5-yl)-5-(ethoxymeth...)
Affinity DataIC50:  1.39E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477650(4-(1-(5-(Difluoromethyl)-4-(6-methoxypyridin-3-yl)...)
Affinity DataIC50:  1.41E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477640(5-(3-(3-(7-Fluorobenzodihydropyran-4-yl)azetidin-1...)
Affinity DataIC50:  1.73E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477581(7-Fluoro-4-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.81E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477636(5-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  1.98E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477647(6-Fluoro-1-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  2.07E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(3-Chloro-1-(1-(5-(ethoxymethyl)-4-(6-methoxypyridi...)
Affinity DataIC50:  2.07E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477649(7-Fluoro-4-(1-(4-(6-methoxypyridin-3-yl)-5-methyl-...)
Affinity DataIC50:  2.30E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477633(5-(3-(3-(6-Fluorobenzofuran-3-yl)azetidin-1-yl)-5-...)
Affinity DataIC50:  2.57E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477635(6-Fluoro-3-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  2.58E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477624(5-(3-(3-(6-Fluoronaphthalen-1-yl)azetidin-1-yl)-5-...)
Affinity DataIC50:  2.60E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477640(5-(3-(3-(7-Fluorobenzodihydropyran-4-yl)azetidin-1...)
Affinity DataIC50:  3.88E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477630(5-(3-(3-(6-Fluorobenzo[b]thiophen-3-yl)azetidin-1-...)
Affinity DataIC50:  4.27E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477642(7-Fluoro-4-(1-(5-(methoxymethyl)-4-(6-methoxypyrid...)
Affinity DataIC50:  4.41E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: